Search results for "Biochemistry"

showing 10 items of 20172 documents

Monoclonal Gammopathy of Ocular Significance (MGOS) - a Series of Corneal Manifestations and Treatment Outcomes

2021

Abstract Introduction Monoclonal gammopathy of ocular significance (MGOS) is a rare subset of monoclonal gammopathy of clinical significance (MGCS) occurring secondary to plasma cell dyscrasia resulting in ocular manifestations. Given the rarity of these conditions, optimal management strategies are not defined; the approach is dependent upon the underlying cause of the monoclonal gammopathy and whether or not the patient's vision is affected. We report our review of 23 cases with MGOS, more specifically on paraproteinemic keratopathy (PPK) the most common form, to obtain a better understanding of the patient characteristics, diagnosis and treatments. Methods We report an international retr…

medicine.medical_specialtyMonoclonal gammopathybusiness.industryImmunologyTreatment outcomemedicineCell BiologyHematologymedicine.symptombusinessBiochemistryDermatologyBlood
researchProduct

2018

Beyond the classical paradigm that presents the Anticipatory Postural Adjustments (APAs) as a manner to create forces that counteract disturbances arising from the moving segment during a pointing task, there is a controversial discussion about the role APAs to facilitate the movement and perform a task accurately. In addition, arm kinematics features are classically used to infer the content of motor planning for the execution and the control of arm movements. The present study aimed to disentangle the conflicting role of APAs during an arm-pointing task in which the subjects reach a central diode that suddenly turns on, while their postural stability was manipulated. Three postures were a…

medicine.medical_specialtyMotor planningGeneral Neuroscience030229 sport sciencesGeneral MedicineKinematicsSittingGeneral Biochemistry Genetics and Molecular BiologyDeceleration time03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationPostural stabilitymedicineMotor planGeneral Agricultural and Biological SciencesPsychologypsychological phenomena and processes030217 neurology & neurosurgeryPeerJ
researchProduct

29 Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome)

2007

medicine.medical_specialtyMucopolysaccharidosis IIbusiness.industryEndocrinology Diabetes and MetabolismHunter syndromeEnzyme replacement therapymedicine.diseaseBiochemistryGastroenterologyEndocrinologyInternal medicineGeneticsmedicinebusinessMolecular BiologyMolecular Genetics and Metabolism
researchProduct

Effects of a Rehabilitation Program on Perceived Environmental Barriers in Older Patients Recovering from Hip Fracture: A Randomized Controlled Trial

2013

Objectives. To study effects of a one-year multicomponent intervention on perceived environmental barriers in hip fracture patients.Design. Randomized controlled trial of a 12-month home-based rehabilitation aiming to improve mobility and function (ISRCTN53680197); secondary analyses.Subjects. Community-dwelling hip fracture patients on average 70 days after trauma (n=81).Methods. Assessments at baseline, 3, 6, and 12 months later included perceived entrance-related barriers (e.g., indoor/outdoor stairs, lighting, floor surfaces, and storage for mobility devices) and perceived barriers in the outdoor environment (poor street condition, hilly terrain, long-distances, and lack of resting plac…

medicine.medical_specialtyMultivariate analysisTime FactorsympäristöArticle Subjectmedicine.medical_treatmentPsychological interventionlcsh:MedicineEnvironmentGeneral Biochemistry Genetics and Molecular Biologylaw.inventionfemoral fracturePhysical medicine and rehabilitationStairsOlder patientsRandomized controlled triallawmedicineta319HumansAgedAged 80 and overHip fractureRehabilitationGeneral Immunology and Microbiologybusiness.industryHip Fractureskotikuntoutuslcsh:RagingCase-control studyGeneral Medicinemedicine.diseaseikääntyminensaavutettavuusCase-Control StudiesMultivariate AnalysisPhysical therapyClinical Studykuntoutuslonkkamurtumaesteettömyys ja saavutettavuusbusinessBioMed Research International
researchProduct

Two-dimensional analysis of tear protein patterns of diabetic patients

2001

In diabetic patients, dry eye and other ocular surface diseases occur more often than in healthy subjects. The aim of this study was to analyze the tear protein patterns of patients suffering from diabetes mellitus type II (dia) and to compare them to the patterns of healthy volunteers (ctrl). Tear proteins of nonstimulated tears of 20 patients (ctrl n=10, dia n=10) were separated using two-dimensional electrophoretic techniques. The protein patterns of each group were analyzed by a multivariate analysis of discriminance. Furthermore, for all spots of each gel, a 50 x 50 variables pH/Mr (molecular weight) array was generated and subsequently analyzed by a multivariate analysis of discrimina…

medicine.medical_specialtyMultivariate analysisbusiness.industryClinical BiochemistryTear proteinsSignificant differenceDiabetes mellitus type IIHealthy subjectsmedicine.diseaseBiochemistryAnalytical ChemistryOphthalmologyDiabetes mellitusHealthy volunteersMedicineTearsbusinessELECTROPHORESIS
researchProduct

2015

Several point mutations have been identified in human aquaporins, but their effects on the function of the respective aquaporins are mostly enigmatic. We analyzed the impact of the aquaporin 2 mutation V71M, which causes nephrogenic diabetes insipidus in humans, on aquaporin structure and activity, using the bacterial aquaglyceroporin GlpF as a model. Importantly, the sequence and structure around the V71M mutation is highly conserved between aquaporin 2 and GlpF. The V71M mutation neither impairs substrate flux nor oligomerization of the aquaglyceroporin. Therefore, the human aquaporin 2 mutant V71M is most likely active, but cellular trafficking is probably impaired.

medicine.medical_specialtyMutationurogenital systemPoint mutationMutantAquaporinBiologymedicine.disease_causeNephrogenic diabetes insipidusmedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyCell biologyEndocrinologyAquaporin 2Internal medicineArginine vasopressin receptor 2medicineProtein oligomerizationFEBS Open Bio
researchProduct

3D virtual histopathology of cardiac tissue from Covid-19 patients based on phase-contrast X-ray tomography

2021

eLife 10, e71359 (2021). doi:10.7554/eLife.71359

medicine.medical_specialtyMyocarditisViral MyocarditisQH301-705.5Science030204 cardiovascular system & hematologyStructure tensorGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineArtificial IntelligencemedicineHumansBiology (General)Intussusceptive angiogenesis030304 developmental biologyx-ray tomography0303 health sciencesGeneral Immunology and MicrobiologySARS-CoV-2business.industryGeneral NeuroscienceMyocardiumQRX-rayHeart600General Medicinemedicine.disease3. Good healthCross section (geometry)MyocarditisEpidemiology and Global Healthcardiac tissueMedicineHistopathologyTomographyTomography X-Ray ComputedCovid-19businessddc:600SynchrotronsResearch ArticleHumanBiomedical engineering
researchProduct

Monitoring and use of antimycotic (micafungin) for systemic use provided by the pharmacy of Marsala Hospital, Italy

2016

Micafungin is an antimycotic drug and represents an important addition to the available therapies for the treatment of systemic fungal infections. Micafungin is used: in the treatment of invasive candidiasis, oesophageal and prophylaxis of <em>Candida</em> infections. It inhibits, in a non-competitive way, the synthesis of 1,3-β-D-glucan, a component of fungal cell wall and is rapidly distributed into the tissues. It has a high-rate respectful bond with plasma protein, which is independent from the concentration of the drug. It is metabolized through the liver, being not subject to intense metabolic transformations until the excretion. There is no evidence of systemic accumulati…

medicine.medical_specialtyNauseaAnemiaPharmacyPlant SciencePharmacyGeneral Biochemistry Genetics and Molecular BiologyHypomagnesemiaExcretion03 medical and health sciencesHospital Pharmacy0302 clinical medicine030225 pediatricsInternal medicineIntensive caremedicineAntimycotic030212 general & internal medicineSicilylcsh:QH301-705.5Antimycotic; Micafungin; Hospital Pharmacybusiness.industryBiochemistry (medical)Micafunginmedicine.diseaseHypokalemiaSurgerylcsh:Biology (General)MicafunginSettore BIO/14 - Farmacologiamedicine.symptombusinessmedicine.drug
researchProduct

Comparative cytoprotective effects of carbocysteine and fluticasone propionate in cigarette smoke extract-stimulated bronchial epithelial cells

2013

Cigarette smoke extracts (CSE) induce oxidative stress, an important feature in chronic obstructive pulmonary disease (COPD), and oxidative stress contributes to the poor clinical efficacy of corticosteroids in COPD patients. Carbocysteine, an antioxidant and mucolytic agent, is effec- tive in reducing the severity and the rate of exacerbations in COPD patients. The effects of carbocysteine on CSE-induced oxidative stress in bronchial epithelial cells as well as the comparison of these antioxidant effects of carbocysteine with those of fluticasone propionate are unknown. The present study was aimed to assess the effects of carbocysteine (10−4 M) in cell survival and intracellular reactive o…

medicine.medical_specialtyNecrosisCell SurvivalNF-E2-Related Factor 2Histone Deacetylase 2ApoptosisSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.disease_causeBiochemistryFluticasone propionateAntioxidantsCell Linechemistry.chemical_compoundNecrosisInternal medicineparasitic diseasesTobaccomedicineHumansFluticasonechemistry.chemical_classificationReactive oxygen speciesOriginal PaperPlant ExtractsCarbocysteineCarbocysteineEpithelial CellsCell BiologyGlutathioneCigarette smoke . Airway epithelial cells . Reactive oxygen speciesGlutathioneAndrostadienesOxidative StressEndocrinologychemistryApoptosisFluticasonemedicine.symptomReactive Oxygen SpeciesOxidative stressHeme Oxygenase-1medicine.drug
researchProduct

Studies on the mechanism of PMN activation II. by triggering the alternative pathway of complement activation

1982

By means of cobra venom factor (CVF) it is demonstrated that the stimulation of hexosemonophosphate shunt (HMPS) of human polymorphonuclear leukocytes (PMN) by zymosan (Z) and dextran sulfate (DS) is caused by at least two modes of activation: (a) via activation caused by phagocytosis, (b) via activated alternative pathway of complement activation (APC). Active factors of APC presented with phagocytizable objects strongly enhance activation of PMN. The effect of APC can be observed in serum-containing as well as in serum-free cultures. It can be demonstrated that in serum-free cultures the factors of APC participating in the activation of PMN are supplied by monocytes. By the use of synthet…

medicine.medical_specialtyNeutrophilsPhagocytosisComplement Pathway AlternativeDose-Response Relationship ImmunologicStimulationMonocyteschemistry.chemical_compoundPhagocytosisInternal medicinemedicineHumansComplement ActivationHematologyChemistryDextran SulfateZymosanZymosanDextransComplement C3HematologyGeneral MedicinePeptide FragmentsCell biologyComplement systemDextran sulfateBiochemistryComplement C3aAlternative complement pathwayCobra venom factorBlut
researchProduct